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improve nerve regeneration
Lihong Fan†, Zefeng Yu†, Jia Li, Xiaoqian Dang and Kunzheng Wang*Abstract
Background: This study evaluated whether Schwann-like cells (SLCs) induced from bone marrow-derived
mesenchymal stem cells (BM-MSCs) transplanted into acellular nerve grafts (ANGs) could repair nerve defects compared
with nerve isografts and ANGs with BM-MSCs.
Methods: BM-MSCs extracted, separated and purified from the bone marrow of rats, and some of the BM-MSCs
were cultured with mixed induction agents that could induce BM-MSCs into SLCs. Either SLCs or BM-MSCs were
seeded onto 10-mm ANGs, and the isografts were chosen as the control. The walking-track test, tibialis anterior
muscle weight measurement, electrophysiological examination, toluidine blue staining, transmission electron
micrographs and immunostaining of S-100 and VEGF in these three groups were evaluated in a 10-mm rat sciatic
injury-repair model.
Results: The walking-track test, tibialis anterior muscle weight measurement and electrophysiological examination
of the sciatic nerve suggested the groups of ANGs with SLCs and isografts obtained better results than the BM-MSC
group (P < 0.05). Meanwhile, the results of the SLCs and isograft groups were similar (P > 0.05). All the histomorphometric
analyses (toluidine blue staining, transmission electron micrographs and immunostaining of S-100 and VEGF) showed
that there were more regenerating nerve fibers in the group of ANGs with SLCs than the BM-MSCs (P < 0.05), but there
was no significant difference between the SLC and isograft groups (P > 0.05).
Conclusions: SLCs seeded in ANGs and isografts show better functional regeneration compared with BM-MSCs seeded
in ANGs. Additionally, SLCs combined with ANGs present almost the same outcome as the isografts. Therefore, SLCs
with ANGs can be a good choice in nerve defect repairs.
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Trauma-induced peripheral nerve injuries affect approxi-
mately 2.8% of patients who undergo surgical intervention
[1]. Unfortunately, in many cases, patients who suffer per-
ipheral nerve injuries experience a permanently impaired
quality of life.
To solve this medical issue, a range of studies and clin-
ical trials have been performed to repair the nerve injuries.
Among all the approaches to repair nerve injuries, autolo-
gous nerve bridges, also known as isografts, which are
regarded as the clinical “gold standard” for repairing nerve
gaps, are the most effective method; however, this method* Correspondence: wkzh1955@163.com
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unless otherwise stated.is also restricted due to some problems, especially limited
donor nerve resources [2]. Therefore, to address this issue,
numerous synthetic and natural biomaterials have become
alternatives. Earlier studies demonstrated some alterna-
tives to induce axon regeneration across nerve gaps, but
their effectiveness was limited [3,4]. The internal structure
and extracellular matrix (ECM) components of nerve
grafts have been demonstrated to be an ideal candidate
for guiding cell migration and nerve fiber elongation
[5,6]. Acellular nerve grafts derived from peripheral nerves
maintain the original structures and ECM components
and cause a low host immune response, even though the
grafts are taken from xenogeneic animals [7].
Schwann cells (SCs) play an important role in nerve
generation, such as producing neurotrophic factors and
causing neurite outgrowth from neurons [8]. Therefore,. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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groups have supplemented acellular nerve grafts with
cultured SCs [9,10]. However, the application of SCs to
treat nerve injures is rare, even obsolete, due to the dis-
advantages, such as limited resources, difficult purifica-
tion protocol, and strong immune reactions [11,12]. Bone
marrow-derived mesenchymal stem cells (BM-MSCs), a
type of stromal cell present in the bone marrow, that pos-
sess multi-directional differentiation potential, have many
clinical advantages, such as easy accessibility, rapid prolif-
eration in culture and successful integration into the host
tissue with a low immune response. Thus, many studies
have been performed to determine whether BM-MSC
therapy, as an alternative to SC therapy, is a promising ap-
proach for repairing nerve injuries [13,14]. Our earlier re-
search and other studies suggest that SC transplantation
induces better axon regeneration than BM-MSCs follow-
ing peripheral nerve injury [15,16]. Luckily, some previous
studies showed that BM-MSCs have the capability to dif-
ferentiate into Schwann-like cells (SLCs) under specific
conditions in vitro and that SLCs have some of the char-
acteristics of SCs that are not present in BM-MSCs
[17,18]. Furthermore, Walsh et al. [19] and Wang et al.
[20] demonstrated that SLCs derived from precursor
cells and different stem cells, respectively, help promote
peripheral nerve regeneration.
Based on past studies, we hypothesize that the
Schwann-like cells induced from bone marrow-derived
mesenchymal stem cells could improve the extent of
axon regeneration. The current study was designed to
determine whether the addition of SLCs could increase




Sprague–Dawley (SD) rats (180–220 g) and York pigs
(approximately 200 kg) that were obtained from the
Laboratory Animal Research Center of Xi'an Jiaotong
University were used. All experimental animals were
housed in a temperature- and humidity-controlled room
with 12-h light/12-h dark and allowed free access to
standard chow and water, and the experimental protocol
was approved by the Animal Ethical Committee of Xi'an
Jiaotong University. All surgical procedures were per-
formed under general anaesthesia via the intraperitoneal
injection of pentobarbital sodium.
Preparation of acellular nerve grafts
Under aseptic conditions, the bilateral intercostal nerves
of anesthetized York pigs were exposed, and the nerve
segments were excised to prepare the ANGs. The con-
nective tissue of the nerves was removed under a light
microscope, and the nerves were then immediatelyplaced in sterile distilled water and cut into 10-mm seg-
ments. Acellular nerves were prepared via optimized
chemical processing, and all the subsequent steps were
conducted based on the previously developed protocol
[21]. Briefly, the nerve tissues were immersed in 0.25% tryp-
sin for 30 min at 37°C, and then rinsed in deionized dis-
tilled water for 4 h. Subsequently, the water was aspirated
and replaced with a solution containing 125 mM SB-10,
10 mM phosphate, and 50 mM sodium. The nerves were
agitated for 15 h. The tissue was rinsed once for 15 minutes
in a washing solution of 50 mM phosphate and 100 mM
sodium. Next, the washing solution was replaced with a so-
lution containing 0.14% Triton X-200, 0.6 mM SB-16,
10 mM phosphate, and 50 mM sodium. After agitating for
24 h, the tissue was rinsed in a washing solution 3 times at
5 minutes per rinse. The nerve segments were again agi-
tated in the SB-10 solution (7 h), washed once, and agitated
in the SB-16/Triton X-200 solution (15 h). Finally, the
tissue segments were washed 3 times for 15 minutes in a
solution containing 10 mM phosphate and 50 mM sodium
and then stored in the same solution at 4°C.
Primary culture of Schwann cells
Primary Schwann cells were obtained according to the
previously published protocols described by Kaewkhaw
et al. [22]. Briefly, the protocol was based on Schwann
cell culture medium containing both mitogens (forskolin
and N2 supplement plus bovine pituitary extract), to
stimulate the growth of Schwann cells and the addition
of D-valine to simultaneously restrict fibroblast over-
growth in Dulbecco’s Modified Eagle’s Medium (DMEM).
BM-MSC preparation
Six to eight-week-old SD rats (n = 5) were euthanized
using diethyl ether, and the long bones were collected
under sterile conditions. The ends of each bone were then
cut off. The bone marrow from each bone was collected
by flushing the bone with α Minimum Essential Medium
Eagle (αMEM) (Sigma, USA) containing 1000 U/ml Peni-
cillin G (Sigma, USA). After filtering, the cells were centri-
fuged at 1000 × g for 5 min. The purified cells were finally
dispersed in αMEM with 15% foetal bovine serum (Sigma,
USA) containing 100 U/ml penicillin and 100 μg/ml
streptomycin (Sigma, USA) [23].
Preparation of SLCs
After being subcultured at a concentration of 1 × 106 cells/
cm2, BM-MSCs were incubated in αMEM containing
1 mM BME without serum for 24 h. The culture medium
was then replaced with αMEM containing 10% FBS and
35 ng/ml at-RA (Sigma, USA). After three days, the cells were
finally transferred to inducer medium containing αMEM,
10% FBS and trophic factors of 5 μM FSK (Calbiochem,
CA), 10 ng/ml bFGF (Peprotech, UK), 5 ng/ml PDGF
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USA). The cells were cultured for 10 days [24,25].
Immunostaining of cultured cells
Some of the SLCs cultured on chamber slides were fixed
in 4% (w/v) paraformaldehyde at 4°C for 20 min. The
cells were then incubated overnight at 4°C with primary
antibodies against S-100 (rabbit polyclonal; 1:200; Santa
Cruz, USA). The following day, the slides were incu-
bated for 2 h with the secondary antibody (goat anti-
rabbit; 1:100; Sigma, USA). The slides were examined
under a microscope (Olympus SZ51) and the numbers
of immuno-positive cells were counted in a minimum
total of 100 cells per experiment. Cultures of Schwann
cells and BM-MSCs were similarly stained as positive
and negative controls according to the antibodies used.
Construction of two types of nerve grafts in vitro
The isolated BM-MSCs and SLCs were utilized for seed-
ing acellular-allogenic grafts. A single cell suspension
containing 2% gelatine was prepared at a concentration
of 2 × 107 cells/ml, and the acellular nerves were pre-
incubated in complete medium at 37°C for 3 h. A total
volume of 30 μl of cell suspension was injected into the
nerve graft using a microinjector, resulting in a loading
of 6 × 105 cells per graft. To perform the injection, under
a dissecting microscope, the microinjector was inserted
through the full length of the nerve segment, and the
cells were injected in equal volumes at four evenly
spaced points as the injector was withdrawn from the
nerve. The nerve grafts implanted with BM-MSCs and
SLCs were then immersed in DMEM supplemented with
10% FBS and incubated at 37°C with 5% CO2 under fully
humidified conditions. After 3 days in culture, some
nerve scaffolds containing BM-MSCs or SLCs were used
to bridge the 10-mm nerve gap in vivo [26,27].
Experimental design and surgery
All the SD rats were randomly divided into three groups
(n = 15 per group): group A, SLC-laden ANG; group B,
BM-MSC-laden ANG; and group C, isograft group. The
rats were anesthetized with sodium pentobarbital, and
the surgical site was shaved and sterilized with 75% etha-
nol 3 times. A skin incision was then made along the
femoral axis, and the thigh muscles were separated, ex-
posing the sciatic nerve. The right sciatic nerves were
cut near the obturator tendon at mid-thigh and allowed
to retract. The distal nerve stumps were transected to
create 10-mm nerve defects. Both stumps of the sciatic nerve
gap were bridged using SLC-laden ANG (ANG-SLCs) or
BM-MSC-laden ANG (ANG-BM-MSCs) with 10–0 nylon
monofilament. The transplantation of the isografts served
as a control. For the isograft group, the 10-mm segments
of sciatic nerves were resected, reversed 180°, and thensutured back onto the nerves. The wounds of the rats
were rinsed with 40,000 U of gentamycin sulphate to re-
duce the chance of infection. The muscles were reapposed
with 4–0 vicryl sutures, and the skin incision was clamped
shut with wound clips. After surgery, the rats were placed
under a warming light, allowed to recover from anaesthe-
sia, and then housed separately with food and water ad
libitum in a colony room maintained at a constant
temperature (19 ~ 22°C) and humidity (40% ~ 50%) on a
12:12 h light/dark cycle.
Walking-track test
The rat sciatic function index (SFI) score was evaluated
as previously described [28-30]. At different time points
(2, 4, 8, and 12 weeks), the hind feet of the rats were
dipped in ink, and the rats were allowed to walk across a
plastic tunnel so that the footprints could be recorded
on paper loaded onto the bottom of the tunnel. The dis-
tance between the top of the third toe and the most pos-
terior part of the foot in contact with the ground (print
length, PL), the distance between the first and fifth toes
(toe spread, TS), and the distance between the second
and fourth toes (ITS) were measured on the experimental
side (EPL, ETS, and EITS, respectively) and on the contra-
lateral normal side (NPL, NTS, and NITS, respectively).
The SFI was generated as follows: SFI = 109.5 × (ETS-
NTS)/NTS-38.3 × (EPL-NPL)/NPL + 13.3 × (EITS-NITS)/
NITS-8.8. In general, a SFI value approximately 0 indi-
cated normal nerve function and a value of approxi-
mately −100 indicated total dysfunction.
Electrophysiology
Electrophysiological tests were performed 12 weeks after
the surgery. Under sodium pentobarbital anaesthesia,
the previous surgical site at the mid-thigh level was re-
opened, and the left sciatic nerve was re-exposed. Bipolar
hooked platinum recording and stimulating electrodes
were used to induce and record electrical activity. Bipolar
stimulating electrodes were placed on the nerve proximal
to the graft while recordings were obtained distal to the
graft from the nerve and from the belly of the gastrocne-
mius muscle. The distance between the two electrodes
was measured with a sliding calliper with 0.2 mm preci-
sion. Electrical stimuli were applied with an intensity of
1–30 mA to ensure the maximum waveform and prevent
independent muscle contraction and also applied sequen-
tially to the sciatic nerve trunk at the proximal and distal
ends of the graft. The recordings of compound muscle
action potential amplitude and nerve conduction vel-
ocity were recorded following a supramaximal stimulus
delivered by the proximal electrodes. The procedures
were performed on a heating blanket to maintain a body
temperature of 37°C. The evoked peak amplitude of
compound muscle action potential (CMAP) and the
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were recorded using MedLab V6.0 system (Meiyikeji,
China). The stimuli duration were 0.1-0.2 ms, and the
stimulation frequency was 1 Hz.
Tibialis anterior muscle weight measurement
12 weeks after surgery, the bilateral tibialis anterior
muscle was dissected completely from the origin to the
insertion and weighed immediately with an electron
scale with 0.0001 g precision. The weight ratio of the op-
erated side was expressed as a percentage of the muscle
weight on the contralateral normal side.
Histopathological observation
After being sacrificed, the never grafts of the rats were
fixed by perfusion with 4% paraformaldehyde in 0.1 M
phosphate buffer (pH 7.4), and the middle of the nerve
grafts was harvested for TEM analysis. In addition,
500 nm semi-thin cross-sections of the specimens were
cut and stained with 1% toluidine blue solution for the
light microscopy study. In randomly selected high power
fields, the total number of nerve fibers, myelin sheath
thickness and myelinated fiber diameter of the regener-
ated nerves were analyzed with Image Pro Plus 6.0. The
results were used to calculate the G-ratios (ratio of axon
diameter to fiber diameter) [14,31].
Immunostaining analysis of the regenerated tissues
Briefly, serial 8-μm-thick sections of the middle of the
nerve graft were cut on a cryostat, mounted onto poly-Figure 1 H&E staining and transmission electron microscopy of norm
sections of normal nerves (A) and acellular nerves (B). Following decellular
Transmission electron microscopy of cross-sections of normal nerves (C) an
sheaths were absent in the acellular nerves. Scale bar = 20 μm (A, B), 1 μmL-lysine-coated slides, and subjected to immunohisto-
chemical analysis with antibodies against S-100 (Sigma,
1:200 dilution) and VEGF (Sigma, 1:200 dilution). The im-
munoreactive signals were visualized by goat anti-mouse
IgG (Jackson, 1:200 dilution). In randomly selected high
power fields, the integrated optical density (IOD) of a
positive immunological reaction was analyzed by Image-
Pro Plus 6.0 [32,33].
Statistical analysis
The data were expressed as the mean ± standard error of
the mean (SEM). The analysis was performed using SPSS
13.0 software. One-way analysis of variance (ANOVA)
followed by Dunnett’s test was used for the comparison
among experimental groups. Non-parametric data were
compared among the experimental groups using the
Mann–Whitney U-test. P values less than 0.05 were
considered statistically significant.
Results
Structure of the acellular nerves
For the acellular nerves, following decellularization,
H&E staining showed that the endoneurial tubes were
empty. The cells, axons and myelin sheath were removed
completely, and the structural integrity of the basilar
membrane was well retained (Figure 1B). In addition, the
TEM ultrastructural analysis further demonstrated that
the axons and myelin sheath were absent in the acellular
nerves and that the collagen fibers were arranged regularly
to construct the wall of the basal lamina tubes, whichal nerves and acellular nerves. H&E staining of the longitudinal
ization, H&E staining showed that the endoneurial tubes were empty.
d acellular nerves (D). TEM demonstrated that axons and myelin
(C, D).
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normal nerve’s myelin sheath and cell nuclei were still
intact (Figures 1A and C).
Immunocytochemistry of SLCs
We used the expression of S-100, which is a specific
marker of Schwann cells, to estimate the characteristics
of the SLCs. Almost all of the SLCs and SCs were posi-
tive in response to the S-100 antibody (Figure 2). After
ten days of induction, the expression of the S-100 pro-
tein was demonstrated in the cytoplasm of the SLCs. In
evaluating the differentiation of BM-MSCs to SLCs, im-
munocytochemical staining revealed that BM-MSCs to
SLCs were positive for S-100 (82.3 ± 5.8%).
Evaluation of the nerve regeneration and functional
recovery
At no time point following surgery did the wounds of
any study group show swelling and/or effusion. At 12 to
20 days post-operation, the wounds of all groups had
healed spontaneously. Red swelling and trophic ulcers
appeared on the footplates on the operated sides. Four
to five weeks later, muscular atrophy of the extremities
on the operated side occurred in all groups. After ap-
proximately 8 weeks, the footplate ulcers had almost
healed, whereas the muscular atrophy and motor func-
tion were only partially recovered. There was minimal
adherence between the transplants and surrounding tis-
sues, and the morphology of the transplanted nerves was
intact without signs of edema.
The efficacy of SLCs on motor functional improve-
ment in the peripheral nerve-injured rats was evaluated
based on SFI and electrophysiological analysis. The re-
sults showed that the SFI value was increased signifi-
cantly in group A compared with group B at each timeFigure 2 Immunocytochemistry of S-100. Immunocytochemistry of S-10
SLCs became positive in response to the S-100 antibody (brown staining in
were used as a positive control. Scale bar = 20 μm.point tested (P < 0.05). No significant difference in the
SFI value was observed between groups A and C (P > 0.05).
These results indicated that the combination of SLCs was
more effective in promoting the recovery of motor function
than BM-MSCs (Figure 3).
We also performed electrophysiological studies to
determine whether the axons had regenerated through
the entire length of the operated sciatic nerves. After
12 weeks, group C showed the best electrophysiological
parameters (CMAP: 4.86 ± 1.81 mV; conduction velocity:
26.17 ± 5.11 m/s), followed by group A (CMAP: 4.21 ±
1.53 mV; conduction velocity: 22.64 ± 5.91 m/s) and
group B (CMAP: 2.36 ± 1.03 mV; conduction velocity:
13.67 ± 4.98 m/s). Groups A and C did not differ in their
electrophysiological tests (P > 0.05), but group C showed
significantly subordinate results compared with the other
groups (P < 0.05 for both tests, Figure 4).
The results of the tibialis anterior muscle weight pres-
ervation of the different groups are shown in Figure 5.
As an index of muscle atrophy, the tibialis anterior
muscle weight ratio in group A (59.3 ± 4.6%) were sig-
nificantly higher than in group B (38.5 ± 3.9%, P < 0.05,
Figure 5). Moreover, no significant difference in the tibi-
alis anterior muscle weight ratio was calculated between
groups C (62.1 ± 4.5%) and A (P > 0.05, Figure 5), which
indicates that acellular grafts with SCLs postpone muscle
atrophy.
After repairing the 10-mm sciatic nerve gaps, histo-
logical examinations were performed. Toluidine blue
staining and TEM were performed to assay whether the
implanted nerve graft promoted axon regeneration. In
Figures 6A-C and D-F, 12 weeks after transplantation,
toluidine blue staining and TEM showed numerous
myelin sheaths within the graft. However, group A showed
superior results in the total number of nerve fibers (P < 0.05),0 in SLCs (A), BM-MSCs (B) and Schwann cells (C). After induction, the
the cytoplasm), whereas the BM-MSCs were negative. Schwann cells
Figure 3 The quantitative analysis of SFI value. Typical walking
tracks were obtained from the three experimental groups at 0, 2, 4,
8 and 12 weeks after surgery, and the SFI value was calculated. The
SFI values in the isograft and ANG + SLC groups were significantly
higher than in the ANG + BM-MSC group. The data are shown as the
mean ± SEM, *P < 0.05 vs. the ANG + BM-MSC group (n = 15).
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diameter (P < 0.05) compared with group B (Figure 7A-C).
Additionally, groups A and C showed no differences in
these three morphological indices (P > 0.05, Figure 7A-C).
Furthermore, the G-ratios were not significantly different
among the three groups (P > 0.05, Figure 7D).
The figures of immunostaining revealed that compared
with group B 12 weeks after surgery, group A showed a
significantly higher level in both S-100 (P < 0.05) and
VEGF (P < 0.05, Figure 8). At the same time, the S-100
and VEGF levels in groups A and C were similar (P > 0.05,
Figure 8).
Discussion
Peripheral nerve injury causes the loss of nerve func-
tions, which results in the loss of neurological functionalFigure 4 Electrophysiological recovery analysis 12 weeks after graftin
muscle action potential (CMAP) was significantly greater in the isograft and
of the nerve conduction velocity recording (B) were similar to those of the
with the ANG + BM-MSC group (n = 15).and an impaired quality of life [34,35]. Nerve regener-
ation and functional recovery after peripheral nerve in-
jury is a clinical challenge. To overcome this problem,
many studies and clinical trials have been performed.
Autologous nerve bridges are the most effective way to
induce axon regeneration and promote neurological re-
covery, but this technique is also restricted due to some
limitations, such as a limited supply of nerve grafts [2].
The proper decellularization of peripheral nerves could
reduce the immune response while retaining the internal
structure and extracellular matrix components of the
nerve [26,36]. However, with ANGs alone, the length of
axon regeneration is limited [37]. The inclusion of neur-
onal support cells is critical for axonal proliferation [38].
Earlier studies revealed that the implantation of BM-
MSCs within acellular nerve grafts can enhance the re-
generation of sciatic nerve axons compared with ANGs
[17,39-43]. However, some studies revealed that combin-
ing BM-MSCs with ANGs results in less axon regener-
ation compared with ANGs containing SCs [15,16,44].
Although the SC treatment induces good axon regener-
ation [27], it is rarely used due to their limited supply
and the strong immune reactions they induce [13,14].
Based on previous studies, taking all the advantages
together, we developed the idea of inducing BM-MSCs
into Schwann cells, also known as Schwann-like-cells,
and combining SLCs with ANG as the graft for periph-
eral nerve repair.
In this study, we created the acellular nerve through
the use of trypsin, deionized distilled water and chemi-
cals (Triton X-200, sulfobetaine-16 and sulfobetaine-10),
the three key procedures, that were conducted based on
the previously developed protocol [21]. This protocol re-
moved cellular material from nerve tissue while preserv-
ing the natural ECM structure. Nerve grafts created with
this decellularization protocol demonstrated the ability
to support and guide regenerating nerves without elicitingg and experimental treatment. The amplitude of the compound
ANG + SLC groups than in the ANG + BM-MSC group (A). The results
CMAP. The data are shown as the mean ± SEM, *P < 0.05 compared
Figure 5 The ratio of tibialis the anterior muscle weight. The
ratio of the tibialis anterior muscle weight in the ANG + BM-MSC
group was significantly lower than that in the other two groups. The
data are shown as the mean ± SEM, *P < 0.05 compared with the
ANG + BM-MSC group (n = 15).
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with transplanted tissues, as shown in our study.
This study shows the strong plasticity of BM-MSCs by
their differentiation into Schwann-like cells with the typ-
ical spindle-shaped Schwann cell morphology. Further-
more, SLCs and SCs have comparable functional
properties, such as producing a number of neurotrophicFigure 6 Toluidine blue staining and transmission electron micrograp
bar = 10 μm) and transmission electron micrographs (TEM, D-F, scale ba
ANG + BM-MSC (B and E) and isograft (C and F) groups. The isograft gr
group also demonstrated a large number of mature axons, whereas thefactors and causing the neurite growth of neurons,
which are not found in BM-MSCs [45]. Keilhoff et al.
and Wang et al. demonstrated that SLCs can provide
better nerve regeneration than BM-MSCs [16,20].
Here, we injected SLCs or BM-MSCs into the ANGs
in equal cell suspension volumes at four evenly spaced
locations [14,26]. Earlier histological evidence demon-
strated that the injected cells will be well arranged along
the longitudinal ANGs, although there will be damage of
the basal lamina tubes caused by the microinjector
[26,46]. Additionally, with this method, we could reduce
the swelling of ANGs caused by suspension injection
and the mechanical stress on injected cells and obtain
better cell survivals after injection [27].
We selected SFI as a parameter to evaluate the func-
tional recovery after nerve repair [47]. As mentioned
previously, a SFI value of approximately 0 indicates nor-
mal nerve function and a value of approximately −100
indicates total dysfunction. The SFI of the nerve repair
group using acellular nerve grafts supplemented with
SLCs was significantly greater than that of the nerve re-
pairs with the acellular nerve grafts combined with BM-
MSCs (P < 0.05). In addition, the functional recovery of
the SLC group was similar to that of the nerve repair
with the isograft (P > 0.05).
Studies demonstrated that foetal neural stem cells trans-
planted into peripheral nerves after injury can improvehs at 12 weeks postoperatively. Toluidine blue staining (A-C, scale
r = 2 μm) at 12 weeks postoperatively in the ANG + SLC (A and D),
oup showed numerous large well-myelinated axons. The ANG + SLC
ANG + BM-MSC group displayed generally fewer, small fibers.
Figure 7 Total number of nerve fibers, myelin sheath thickness, myelinated fiber diameter and G-ratio. Total number of nerve fibers (A),
myelin sheath thickness (B), myelinated fiber diameter (C) and G-ratio (D) at 12 weeks postoperatively. A, B, and C showed that the results from
the isograft and ANG + SLC groups were significantly higher than those of the ANG + BM-MSC group. However, D showed no difference in the
G-ratio among all groups. The data were shown as the mean ± SEM. *P <0.05, compared with the ANG + BM-MSC group (n = 15).
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denervated muscle by inducing axon regeneration, which
reduces muscle atrophy after peripheral nerve injury [48].
Based on this theory, we chose the tibialis anterior muscle
weight to evaluate nerve regeneration. We found that the
acellular nerve grafts supplemented with SLCs used for
nerve grafts can better maintain muscle weight compared
with nerve repairs with the acellular nerve grafts com-
bined with BM-MSCs (P < 0.05). Furthermore, the SLC
group showed equivalent results to those of the isograft
group in muscle weight (P > 0.05). In this study, we also
chose the nerve electrophysiological function test for
evaluating nerve recovery. As previously known, better
nerve regeneration and axonal myelination would result
in higher amplitude and nerve velocity. We found that the
amplitude of the compound muscle action potential and
nerve conduction velocity from the SLC nerve repair
group showed significantly higher results in electrophysio-
logical function (P < 0.05) compared with the BM-MSC
group and that the SLC group presented almost equal
CMAP and nerve conduction velocity data compared with
the isograft group in the nerve electrophysiological func-
tion test (P > 0.05).
Although the number of nerve fibers, myelinated fiber
diameter, and myelin sheath thickness in the ANG con-
taining SLCs group were similar to those in the isograft
group (P > 0.05), the ANGs containing SLCs produced asignificantly higher number of nerve fibers, greater mye-
linated fiber diameter and greater myelin sheath thickness
than the BM-MSC group (P < 0.05), which indicated that
SLCs were beneficial for improving the nerve regeneration
and maturation of myelinated fibers compared with the
BM-MSC group. The G-ratio (ratio of axon diameter to
fiber diameter) is widely used as a functional and struc-
tural index of optimal axonal myelination [49]. An in-
crease in the G-ratio of fibers may suggest a decrease in
myelination, which has a bad effect on nerve repair. Al-
though we found no significant difference among all
groups (P > 0.05), we could still show a trend in nerve
myelination in the three groups, as we determined at an
early time point in the recovery.
The demonstrated better potency of axon generation
in the SLC group compared with the BM-MSC group is
reflected in the expression patterns of the calcium-
binding protein S-100 (Figure 8G). After being released
into the extracellular space, S-100 stimulates prolifera-
tion, neuronal survival, and differentiation [50]. There-
fore, the differences in supporting nerve regeneration
may easily be attributed to the different levels of this
neurotrophin. Rong et al. [51], demonstrated that
blocking S-100 receptors suppresses peripheral nerve
regeneration.
VEGF is a peptide associated with angiogenesis. It
can promote endothelial cell division and enhance
Figure 8 S-100 and VEGF immunostaining and IOD value analyses at 12 weeks postoperatively. S-100 immunostaining (A-C, scale bar = 10 μm)
and VEGF immunostaining (D-F, scale bar = 20 μm) at 12 weeks postoperatively with SLCs (A and D), BM-MSCs (B and E) and isografts (C and F). The
IOD values of the positive expression of S-100 and VEGF in the regenerated nerves (G). The isograft and ANG+ SLC groups showed a significantly higher
level in both S-100 and VEGF immunostaining compared with the ANG + BM-MSC group. The data were shown as the mean ± SEM. *P <0.05, compared
with the ANG+ BM-MSC group (n = 15).
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ences the behaviour of nerve cells by the neurotrophic
and neuroprotective influences [52,53]. Furthermore, the
VEGF treatment of acellular peripheral nerve isografts en-
hances axon sprouting, resulting in an increased number
of regenerating axons [54]. Studies also noted that VEGF
stimulates Schwann cell invasion and the neovasculariza-
tion of acellular nerve grafts [52]. Based on these studies,
we chose VEGF as an indicator of axon regeneration.
We found that the SLC group showed a greater expres-
sion of VEGF (significantly higher IOD value, P < 0.05)
than the BM-MSC group and that the SLC group
showed an equivalent IOD value compared with the
isograft group (P > 0.05).Conclusions
In conclusion, this study demonstrated that the combin-
ation of an acellular nerve graft with SLCs provides a
microenvironment that increases axon elongation and
myelinization. Meanwhile, the nerve regeneration is fa-
cilitated when compared with the combination of an
acellular nerve graft and BM-MSCs in rats. Additionally,
considering the disadvantages of isografts, supplement-
ing SLCs around the acellular nerve graft might be a bet-
ter candidate for the treatment of a peripheral nerve
defect. Further investigation is needed to study the
mechanism and determine the conditions to optimize
this technique to improve nerve regeneration when used
for peripheral nerve repair.
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